Innovation Pharmaceuticals Inc.
IPIXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001355250
Innovation Pharmaceuticals Inc. was delisted in 2025; its insiders filed their last Form 4 on Jan 4, 2023; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Innovation Pharmaceuticals Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- −1 vs. Q1 2024
- Shares held
- 66.9K
- −10.0K (−13.0%) vs. Q1 2024
- Total value
- $67
- −$872 (−92.9%) vs. Q1 2024
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $13 |
| Q2 2024 | 2 | $67 |
| Q1 2024 | 3 | $939 |
| Q4 2023 | 3 | $417 |
| Q3 2023 | 1 | $0 |
| Q2 2023 | 1 | $0 |
| Q1 2023 | 1 | $220 |
| Q4 2022 | 1 | $0 |
| Q3 2022 | 1 | $0 |
| Q2 2022 | 2 | $0 |
| Q1 2022 | 1 | $0 |
| Q4 2021 | 1 | $0 |
| Q3 2021 | 3 | $4.00K |
| Q2 2021 | 4 | $20.0K |
| Q1 2021 | 4 | $20.0K |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Innovation Pharmaceuticals Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingfisher Capital LLC | 11,000 | $0 | 0.00% | 00.0% | Unchanged |
| Able Wealth Management LLC | 55,894 | $67 | 0.00% | 00.0% | Unchanged |
| Clear Point Advisors Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |